These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11350856

  • 21. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS, Gavin MP, Sturrock RD.
    Adv Exp Med Biol; 2003; 528():557-9. PubMed ID: 12918763
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
    Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL.
    Gut; 2001 Nov; 49(5):725-8. PubMed ID: 11600479
    [Abstract] [Full Text] [Related]

  • 23. Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.
    Kotter I, Deuter C, Stubiger N, Zierhut M.
    J Rheumatol; 2005 Aug; 32(8):1633; author reply 1634. PubMed ID: 16078350
    [No Abstract] [Full Text] [Related]

  • 24. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
    Park J, Cheon JH.
    Gut Liver; 2018 Nov 15; 12(6):623-632. PubMed ID: 29788675
    [Abstract] [Full Text] [Related]

  • 25. Infliximab treatment for severe orogenital ulceration in Behçet's disease.
    Connolly M, Armstrong JS, Buckley DA.
    Br J Dermatol; 2005 Nov 15; 153(5):1073-5. PubMed ID: 16225632
    [No Abstract] [Full Text] [Related]

  • 26. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
    Almoznino G, Ben-Chetrit E.
    Clin Exp Rheumatol; 2007 Nov 15; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
    [Abstract] [Full Text] [Related]

  • 27. [Spondylarthropathy with Behçet's disease: response to infliximab].
    Toussirot E, Schwartz C, Hafsaoui C, Bossert M, Bertolini E, Wendling D.
    Presse Med; 2009 Nov 15; 38(7-8):1183-5. PubMed ID: 19395229
    [No Abstract] [Full Text] [Related]

  • 28. Behçet's syndrome: response to infliximab after failure of etanercept.
    Estrach C, Mpofu S, Moots RJ.
    Rheumatology (Oxford); 2002 Oct 15; 41(10):1213-4. PubMed ID: 12364656
    [No Abstract] [Full Text] [Related]

  • 29. Anti-tumor necrosis factor alpha antibody in the treatment of Behçet's disease.
    Nakamura S, Ohno S.
    Int Ophthalmol Clin; 2005 Oct 15; 45(2):179-89. PubMed ID: 15791165
    [No Abstract] [Full Text] [Related]

  • 30. Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.
    Atzeni F, Leccese P, D'Angelo S, Sarzi-Puttini P, Olivieri I.
    Clin Exp Rheumatol; 2010 Oct 15; 28(4 Suppl 60):S94. PubMed ID: 20868581
    [No Abstract] [Full Text] [Related]

  • 31. [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].
    Andreu M, Ramanoelina J, Fajnkuchen F, Mouthon L, Cohen P, Laroche L, Guillevin L.
    Ann Med Interne (Paris); 2002 Oct 15; 153(6):414-5. PubMed ID: 12486393
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
    Belzunegui J, López L, Paniagua I, Intxausti JJ, Maíz O.
    Clin Exp Rheumatol; 2008 Oct 15; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
    [No Abstract] [Full Text] [Related]

  • 33. The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis.
    Arayssi T, Hamra R, Homeidan F, Uthman I, Awwad ST, Mroue K, Mansour W, Bashshur ZF.
    Clin Exp Rheumatol; 2005 Oct 15; 23(3):427. PubMed ID: 15971438
    [No Abstract] [Full Text] [Related]

  • 34. Refractory pseudoseptic arthritis in Behçet's disease successfully treated with infliximab: a case report and literature review.
    Sifuentes Giraldo WA, Guillén Astete CA, Murillo Romero C, Amil Casas I, Rodríguez García AM, Bachiller Corral FJ.
    Mod Rheumatol; 2014 Jan 15; 24(1):199-205. PubMed ID: 24261779
    [Abstract] [Full Text] [Related]

  • 35. Infliximab in the treatment of posterior uveitis in Behçet's disease. Long term follow up in four patients.
    Lanthier N, Parc C, Scavennec R, Dhôte R, Brézin AP, Guillevin L.
    Presse Med; 2005 Jul 23; 34(13):916-8. PubMed ID: 16142147
    [Abstract] [Full Text] [Related]

  • 36. Anti-tumor necrotic factor antibody for treatment of neuro-Behçet's disease, a case report.
    Borhani Haghighi A, Safari A.
    Clin Neurol Neurosurg; 2008 Mar 23; 110(3):315-6. PubMed ID: 18053588
    [No Abstract] [Full Text] [Related]

  • 37. Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy.
    Ariyachaipanich A, Berkelhammer C, Nicola H.
    Inflamm Bowel Dis; 2009 Dec 23; 15(12):1769-71. PubMed ID: 19177427
    [No Abstract] [Full Text] [Related]

  • 38. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome.
    Seyahi E, Hamuryudan V, Hatemi G, Melikoglu M, Celik S, Fresko I, Yurdakul S, Yazici H.
    Rheumatology (Oxford); 2007 Jul 23; 46(7):1213-4. PubMed ID: 17478465
    [No Abstract] [Full Text] [Related]

  • 39. Effect of infliximab on threatening panuveitis in Behçet's disease.
    Muñoz-Fernández S, Hidalgo V, Fernández-Melón J, Schlincker A, Martín-Mola E.
    Lancet; 2001 Nov 10; 358(9293):1644. PubMed ID: 11716917
    [No Abstract] [Full Text] [Related]

  • 40. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
    Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Suzuki K, Tanaka Y.
    Rheumatology (Oxford); 2009 Aug 10; 48(8):1012-3. PubMed ID: 19465589
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.